Description: Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Home Page: ibs.inc
INBS Technical Analysis
135 West, 41ST Street
New York,
NY
10036
United States
Phone:
646 828 8258
Officers
| Name | Title |
|---|---|
| Mr. Harry Simeonidis | President & CEO |
| Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer |
| Mr. Alex Arzeno | VP of Investor Relations |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0923 |
| Price-to-Sales TTM: | 2.312 |
| IPO Date: | 2020-12-23 |
| Fiscal Year End: | June |
| Full Time Employees: | 50 |